|
The anti-aging industry has entered a new era of cellular endogenous rejuvenation. WELNADS, a high-end research-backed anti-aging brand, is set to launch its highly anticipated new product — STCULTRA. Differentiated from conventional exogenous anti-aging products on the market, STCULTRA focuses on autologous cell activation. Powered by multiple original patented technologies, the brand adheres to endogenous anti-aging principles to develop exclusive oral cellular anti-aging solutions for high-net-worth individuals, reshaping the paradigm of anti-aging intervention.
I. Top-Tier Patent Portfolio: Industry-Leading Rigorous Scientific Research Strength
Unlike common patents derived from simple process improvements, the upcoming STCULTRA is protected by 23 globally original technical patents, all of which are core invention patents in fundamental biological anti-aging research. Developed based on six Nobel Prize in Physiology or Medicine theories and validated by 68 comprehensive human clinical trials, the product stands out in the oral cellular anti-aging field with a complete patent protection system and authentic clinical data backing. Manufactured in strict compliance with medical-grade biopharmaceutical standards, it creates an unmistakable hierarchical gap between ordinary dietary anti-aging supplements and research-grade cellular anti-aging products.
AI-Assisted Enzymatic Patent: Breaking the limitations of traditional artificial extraction technologies, this patent enables intelligent molecular structure regulation, which has been proven to significantly boost biological absorption and lay a solid foundation for efficient stem cell activation.
Stem Cell Homing & Homeostasis Patent: An exclusive technology that builds a nourishing microenvironment for human cells. It achieves targeted stem cell repair and avoids ineffective ingredient loss, delivering far superior repair accuracy than conventional anti-aging products.
Four-Dimensional Closed-Loop Anti-Aging System Patent: An industry-first standardized cellular intervention mechanism covering four core logic dimensions: activation, revitalization, autophagy and immunity. It fundamentally blocks the aging mechanism at the cellular level.
Cryogenic Lyophilization Preservation Patent Technology: Adopting -40℃ vacuum lyophilization combined with 60Co irradiation sterilization, the technology maintains an active ingredient retention rate of up to 98%. Compliant with pharmaceutical-grade safety standards, it ensures extreme product stability.
II. Patented Ingredient Complex & Verified Test Data: Visible Science-Backed Anti-Aging Efficacy
The four core patented active ingredients are all developed based on Nobel Prize-winning scientific research. Rigorous randomized controlled double-blind human trials have been conducted to verify product efficacy with quantifiable data, earning multiple international authoritative certifications.
Activastem Cell Activating Factor: Developed based on the Nobel Prize-awarded HIF-1 pathway research. Clinical tests prove that it can increase the content of aging mesenchymal stem cells by 2.5 to 2.8 times, effectively awakening dormant human stem cells.
Cellrevital Cell Revitalizing Factor: Integrating two Nobel Prize-validated technologies for telomere protection and DNA repair, it delays cellular senescence and sustainably maintains youthful cellular vitality.
Macro-Seno Cellular Autophagy Factor: A 120-day human controlled trial confirms that this factor can optimize human exercise endurance and efficiently eliminate senescent cells and metabolic waste in the body.
Immune-Shield Immune Protection Factor: Winner of the Whole Foods Immunity Gold Award. Verified by 312 human trials, it reduces the incidence of colds by 30%, effectively balances chronic inflammation and builds a solid immune defense barrier.
III. New Product Preview: Empowered by Premium Scientific Research, Awaiting Official Launch
Beyond its robust patented technologies, STCULTRA is formulated with three rare imported plant extracts. Certified by GMP and HACCP international quality systems, the product has completed safety assessments covering people aged 20 to 80, with zero side effects and no physiological dependence. Empowered by cutting-edge technologies, it achieves all-round improvements in six dimensions: energy revitalization, high-quality sleep, joint repair, skin anti-aging, metabolic purification and immune enhancement.
As an international high-end cellular anti-aging research brand, WELNADS operates two scientific research and production bases in the United States and Hong Kong. Focusing on non-invasive oral cellular anti-aging tracks, the brand is committed to the transformation of high-value patented technologies. Evolving from superficial exogenous nutrient supplementation to endogenous cellular regeneration, WELNADS redefines the high-end anti-aging industry with medical-grade scientific research standards.
Backed by three core strengths — 23 patents, Nobel Prize-derived technologies and verified clinical data, STCULTRA is poised to launch officially. It will usher in a new era of high-end endogenous cellular anti-aging for high-net-worth consumer groups.
|（注：文档部分内容可能由 AI 生成）
|
Home > News >